262 related articles for article (PubMed ID: 1357002)
1. Modulation of airway inflammation in cystic fibrosis. In vivo suppression of interleukin-8 levels on the respiratory epithelial surface by aerosolization of recombinant secretory leukoprotease inhibitor.
McElvaney NG; Nakamura H; Birrer P; Hébert CA; Wong WL; Alphonso M; Baker JB; Catalano MA; Crystal RG
J Clin Invest; 1992 Oct; 90(4):1296-301. PubMed ID: 1357002
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics of recombinant secretory leukoprotease inhibitor aerosolized to normals and individuals with cystic fibrosis.
McElvaney NG; Doujaiji B; Moan MJ; Burnham MR; Wu MC; Crystal RG
Am Rev Respir Dis; 1993 Oct; 148(4 Pt 1):1056-60. PubMed ID: 8105734
[TBL] [Abstract][Full Text] [Related]
3. Neutrophil elastase in respiratory epithelial lining fluid of individuals with cystic fibrosis induces interleukin-8 gene expression in a human bronchial epithelial cell line.
Nakamura H; Yoshimura K; McElvaney NG; Crystal RG
J Clin Invest; 1992 May; 89(5):1478-84. PubMed ID: 1569186
[TBL] [Abstract][Full Text] [Related]
4. Anti-neutrophil elastase defense of the normal human respiratory epithelial surface provided by the secretory leukoprotease inhibitor.
Vogelmeier C; Hubbard RC; Fells GA; Schnebli HP; Thompson RC; Fritz H; Crystal RG
J Clin Invest; 1991 Feb; 87(2):482-8. PubMed ID: 1671391
[TBL] [Abstract][Full Text] [Related]
5. Recombinant secretory leukoprotease inhibitor augments glutathione levels in lung epithelial lining fluid.
Gillissen A; Birrer P; McElvaney NG; Buhl R; Vogelmeier C; Hoyt RF; Hubbard RC; Crystal RG
J Appl Physiol (1985); 1993 Aug; 75(2):825-32. PubMed ID: 7901193
[TBL] [Abstract][Full Text] [Related]
6. Aerosolization of recombinant SLPI to augment antineutrophil elastase protection of pulmonary epithelium.
Vogelmeier C; Buhl R; Hoyt RF; Wilson E; Fells GA; Hubbard RC; Schnebli HP; Thompson RC; Crystal RG
J Appl Physiol (1985); 1990 Nov; 69(5):1843-8. PubMed ID: 2272977
[TBL] [Abstract][Full Text] [Related]
7. Effects of native and oxidation-resistant secretory leukoprotease inhibitor on cystic fibrosis sputum: inhibition of neutrophil elastase activity and of sputum-induced secretion from porcine tracheal submucosal glands.
Schuster A; Hansen G; Zubrod-Eichert C; Wahn V
Pediatr Res; 1996 Nov; 40(5):732-7. PubMed ID: 8910939
[TBL] [Abstract][Full Text] [Related]
8. Use of secretory leukoprotease inhibitor to augment lung antineutrophil elastase activity.
Vogelmeier C; Gillissen A; Buhl R
Chest; 1996 Dec; 110(6 Suppl):261S-266S. PubMed ID: 8989162
[TBL] [Abstract][Full Text] [Related]
9. Protease-antiprotease imbalance in the lungs of children with cystic fibrosis.
Birrer P; McElvaney NG; Rüdeberg A; Sommer CW; Liechti-Gallati S; Kraemer R; Hubbard R; Crystal RG
Am J Respir Crit Care Med; 1994 Jul; 150(1):207-13. PubMed ID: 7912987
[TBL] [Abstract][Full Text] [Related]
10. Intravenous recombinant secretory leukoprotease inhibitor augments antineutrophil elastase defense.
Birrer P; McElvaney NG; Gillissen A; Hoyt RF; Bloedow DC; Hubbard RC; Crystal RG
J Appl Physiol (1985); 1992 Jul; 73(1):317-23. PubMed ID: 1354669
[TBL] [Abstract][Full Text] [Related]
11. Recombinant human secretory leukocyte-protease inhibitor: in vitro properties, and amelioration of human neutrophil elastase-induced emphysema and secretory cell metaplasia in the hamster.
Lucey EC; Stone PJ; Ciccolella DE; Breuer R; Christensen TG; Thompson RC; Snider GL
J Lab Clin Med; 1990 Feb; 115(2):224-32. PubMed ID: 2299266
[TBL] [Abstract][Full Text] [Related]
12. Modulation of secretory leukoprotease inhibitor gene expression in human bronchial epithelial cells by phorbol ester.
Maruyama M; Hay JG; Yoshimura K; Chu CS; Crystal RG
J Clin Invest; 1994 Jul; 94(1):368-75. PubMed ID: 7913712
[TBL] [Abstract][Full Text] [Related]
13. Regulation of secretory leukocyte proteinase inhibitor (SLPI) production by human bronchial epithelial cells: increase of cell-associated SLPI by neutrophil elastase.
van Wetering S; van der Linden AC; van Sterkenburg MA; Rabe KF; Schalkwijk J; Hiemstra PS
J Investig Med; 2000 Sep; 48(5):359-66. PubMed ID: 10979241
[TBL] [Abstract][Full Text] [Related]
14. Safety and efficacy of recombinant alpha(1)-antitrypsin therapy in cystic fibrosis.
Martin SL; Downey D; Bilton D; Keogan MT; Edgar J; Elborn JS;
Pediatr Pulmonol; 2006 Feb; 41(2):177-83. PubMed ID: 16372352
[TBL] [Abstract][Full Text] [Related]
15. Effects of sivelestat on bronchial inflammatory responses after esophagectomy.
Yamaguchi K; Sugasawa Y; Takeuchi K; Kugimiya T; Kumakura S; Iwanuma Y; Kajiyama Y; Tsurumaru M; Nagaoka I; Inada E
Int J Mol Med; 2011 Aug; 28(2):187-92. PubMed ID: 21567070
[TBL] [Abstract][Full Text] [Related]
16. [Therapy of lung diseases with antiproteases].
Vogelmeier C; Buhl R
Pneumologie; 1994 Feb; 48(2):57-62. PubMed ID: 7910401
[TBL] [Abstract][Full Text] [Related]
17. Relationship between antimicrobial proteins and airway inflammation and infection in cystic fibrosis.
Sagel SD; Sontag MK; Accurso FJ
Pediatr Pulmonol; 2009 Apr; 44(4):402-9. PubMed ID: 19283840
[TBL] [Abstract][Full Text] [Related]
18. [Early bronchial inflammation in cystic fibrosis].
Puchelle E
J Soc Biol; 2002; 196(1):29-35. PubMed ID: 12134630
[TBL] [Abstract][Full Text] [Related]
19. Human airway surface epithelial regeneration is delayed and abnormal in cystic fibrosis.
Hajj R; Lesimple P; Nawrocki-Raby B; Birembaut P; Puchelle E; Coraux C
J Pathol; 2007 Feb; 211(3):340-50. PubMed ID: 17186573
[TBL] [Abstract][Full Text] [Related]
20. Induction of interleukin-8 release by lung epithelium with cystic fibrosis epithelial lining fluid is marginally affected by inhibitors of interleukin-1beta.
Coulter KR; Allen ED; Hart J; Wewers MD; Castile RG; Knoell DL
Pharmacotherapy; 2000 Jan; 20(1):64-74. PubMed ID: 10641976
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
